2.605
price up icon3.17%   0.08
after-market Handel nachbörslich: 2.61 0.005 +0.19%
loading

Finanzdaten der Galectin Therapeutics Inc-Aktie (GALT)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
0.91%
9.648
9.561 9.166 9.003 10.34
Interest Income/Expense
24.20%
1.052
0.847 0.835 0.65 0.46
Operating Income/Loss
0.91%
-9.648
-9.561 -9.166 -9.003 -10.34
Nonoperating Income/Loss
322.25%
-1.841
-0.436 -1.262 -0.111 -1.185
Income/Loss From Continuing Operations Before Tax
14.92%
-11.49
-9.997 -10.43 -9.114 -11.53
Income/Loss From Continuing Operations After Tax
14.92%
-11.49
-9.997 -10.43 -9.114 -11.53
Net Income/Loss
14.92%
-11.49
-9.997 -10.43 -9.114 -11.53
Preferred Stock Dividends And Other Adjustments
87.30%
0.008
0.063 -0.006 0.063 -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
10,792%
61.98
0.569 59.70 59.58 59.48
Diluted Average Shares
10,792%
61.98
0.569 59.70 59.58 59.48
Basic Earnings Per Share
18.75%
-0.19
-0.16 -0.24 -0.15 -0.19
Diluted Earnings Per Share
18.75%
-0.19
-0.16 -0.24 -0.15 -0.19
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
87.30%
0.008
0.063 -0.006 0.063 -
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):